IGM Biosciences banks a $103M megaround on its quest to pioneer a new kind of cancer-fighting antibody

IGM Biosciences banks a $103M megaround on its quest to pioneer a new kind of cancer-fighting antibody

Source: 
Endpoints
News Tags: 
snippet: 

A low-profile biotech out to shake up how the industry imagines antibody therapeutics is attracting some eyeballs today with a $103 million megaround.